Aldosterone is associated with left ventricular hypertrophy in hemodialysis patients

Conclusion:
The data presented are consistent with a pathogenic role of aldosterone in left ventricular hypertrophy in patients with chronic kidney dialysis in dialysis patients.

Trial registration:
ClinicalTrials.gov identifier: NCT01128101.

Source: Therapeutic Advances in Cardiovascular Disease - August 28, 2016 Category: Cardiology Authors: Feniman De Stefano, G. M. M., Zanati-Basan, S. G., De Stefano, L. M., Silva, V. R. O. e., Xavier, P. S., Barretti, P., da Silva Franco, R. J., Caramori, J. C. T., Martin, L. C. Tags: Reviews Source Type: research